Dr. Muhammad Ali is a bioinformatician by training. He has joined the Cruchaga lab at Washington University in St. Louis (WUSTL) as a postdoctoral research associate. His area of expertise is computational system biology, i.e. integrative analysis of multi-omics data from disease-related case-control studies, and network-based predictive disease modeling. In Cruchaga Lab, he is expanding his knowledge in the area of human genetics and performing genome-wide association studies (GWAS) analysis to identify novel and common genetic variants associated with neurodegenerative disorders. He aims at utilizing the multi-omics data from human brain tissues for identifying novel genes implicated in AD, to provide biological context for the risk genes and to identify novel molecular biomarkers and new therapeutic targets.